RUBÉN
QUINTANA CABRERA
Investigador en el periodo 2010-2022
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (7)
2022
-
Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis
Nature Communications, Vol. 13, Núm. 1
2021
-
Intertwined ROS and Metabolic Signaling at the Neuron-Astrocyte Interface
Neurochemical Research, Vol. 46, Núm. 1, pp. 23-33
-
Opa1 relies on cristae preservation and ATP synthase to curtail reactive oxygen species accumulation in mitochondria
Redox Biology, Vol. 41
2019
-
ER Stress Priming of Mitochondrial Respiratory suPERKomplex Assembly
Trends in Endocrinology and Metabolism
-
PARP inhibitor PJ34 protects mitochondria and induces DNA-damage mediated apoptosis in combination with cisplatin or temozolomide in B16F10 melanoma cells
Frontiers in Physiology, Vol. 10, Núm. MAY
2018
-
The cristae modulator Optic atrophy 1 requires mitochondrial ATP synthase oligomers to safeguard mitochondrial function
Nature Communications, Vol. 9, Núm. 1
2012
-
γ 3-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor
Nature Communications, Vol. 3